Business Description
CareDx Inc
NAICS : 325413
SIC : 8071
ISIN : US14167L1035
Share Class Description:
CDNA: Ordinary SharesDescription
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.28 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.55 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.64 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | -107.8 | |||||
| 3-Year EPS without NRI Growth Rate | -78.1 | |||||
| 3-Year Book Growth Rate | -3.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.84 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.87 | |||||
| 9-Day RSI | 32.1 | |||||
| 14-Day RSI | 35.04 | |||||
| 6-1 Month Momentum % | 302.38 | |||||
| 12-1 Month Momentum % | 506.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.09 | |||||
| Quick Ratio | 3.85 | |||||
| Cash Ratio | 2.92 | |||||
| Days Inventory | 67.12 | |||||
| Days Sales Outstanding | 68.97 | |||||
| Days Payable | 33.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 2.65 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.98 | |||||
| Operating Margin % | -25.92 | |||||
| Net Margin % | -53.73 | |||||
| FCF Margin % | -7.51 | |||||
| ROE % | -50.47 | |||||
| ROA % | -33.23 | |||||
| ROIC % | -39.68 | |||||
| 3-Year ROIIC % | -184.97 | |||||
| ROC (Joel Greenblatt) % | -98.12 | |||||
| ROCE % | -18.98 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 51.62 | |||||
| PS Ratio | 3.99 | |||||
| PB Ratio | 4.4 | |||||
| Price-to-Tangible-Book | 6.38 | |||||
| EV-to-EBIT | -13.19 | |||||
| EV-to-EBITDA | -17.9 | |||||
| EV-to-Revenue | 3.42 | |||||
| EV-to-Forward-Revenue | 2.94 | |||||
| EV-to-FCF | -45.55 | |||||
| Price-to-Median-PS-Value | 1.36 | |||||
| Price-to-Net-Current-Asset-Value | 9.84 | |||||
| Price-to-Net-Cash | 43.39 | |||||
| Earnings Yield (Greenblatt) % | -7.58 | |||||
| FCF Yield % | -1.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CareDx Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 297.084 | ||
| EPS (TTM) ($) | -2.98 | ||
| Beta | 2.65 | ||
| Volatility % | 124.26 | ||
| 14-Day RSI | 35.04 | ||
| 14-Day ATR ($) | 1.723646 | ||
| 20-Day SMA ($) | 26.53925 | ||
| 12-1 Month Momentum % | 506.31 | ||
| 52-Week Range ($) | 5.2 - 34.84 | ||
| Shares Outstanding (Mil) | 52.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CareDx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CareDx Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CareDx Inc Frequently Asked Questions
What is CareDx Inc(CDNA)'s stock price today?
The current price of CDNA is $22.13. The 52 week high of CDNA is $34.84 and 52 week low is $5.20.
When is next earnings date of CareDx Inc(CDNA)?
The next earnings date of CareDx Inc(CDNA) is 2024-11-01 Est..
Does CareDx Inc(CDNA) pay dividends? If so, how much?
CareDx Inc(CDNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers